Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent mental health condition that affects millions of adults and children worldwide. The search for effective treatment options has led to the development of various medications, including the recently approved Qelbree (viloxazine extended-release capsules). This comprehensive guide will provide you with essential information about Qelbree, including its indications, safety information, potential side effects, and more. Plus a chance for you to sign up for a free insider account where you will receive a free fidget spinner!
Introduction to Qelbree
Qelbree is a prescription medication used to treat ADHD in adults and children aged six years and older. The drug’s active ingredient, viloxazine, has been formulated into an extended-release capsule to provide a steady and continuous release of the medication throughout the day.
How Qelbree Works
Qelbree’s exact mechanism of action is not entirely understood. However, it is believed to work by modulating the levels of certain neurotransmitters in the brain, such as norepinephrine and serotonin, which play a crucial role in regulating attention, impulsivity, and hyperactivity.
Important Safety Information about Qelbree
Before starting Qelbree, it is essential to be aware of the potential risks and safety concerns associated with its use.
1. Suicidal Thoughts and Actions
Qelbree may increase the risk of suicidal thoughts and actions in children and adults with ADHD, particularly within the first few months of treatment or when the dose is changed. If you or your child have a history of suicidal thoughts or actions or a family history of such tendencies, inform your doctor before starting Qelbree.
It is crucial to monitor mood, behavior, thoughts, and feelings during treatment with Qelbree and report any new or sudden changes in these symptoms to your healthcare provider immediately.
2. Contraindications
You should not take Qelbree if you or your child:
- Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI within the past 14 days
- Are allergic to viloxazine or any of the other ingredients in Qelbree
Additionally, you or your child should avoid certain medications while taking Qelbree, including alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.
3. Blood Pressure and Heart Rate
Qelbree can cause an increase in blood pressure and heart rate. Your healthcare provider will monitor these vital signs regularly throughout the treatment. If you or your child have a history of high blood pressure or heart-related issues, inform your doctor before starting Qelbree.
4. Manic Episodes
Qelbree may trigger manic episodes in patients with bipolar disorder. If you or your child have a history of bipolar disorder or show any signs of mania while taking Qelbree, inform your healthcare provider immediately.
Precautions and Warnings
Before beginning treatment with Qelbree, it is essential to discuss any existing medical conditions, medications, or supplements with your healthcare provider.
1. Driving and Operating Heavy Machinery
Qelbree may cause drowsiness or fatigue. Do not drive or operate heavy machinery until you know how the medication affects you or your child. If you or your child experience excessive sleepiness or fatigue while taking Qelbree, inform your healthcare provider.
2. Pregnancy and Breastfeeding
The safety of Qelbree during pregnancy and breastfeeding is not well-established. If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential risks and benefits of using Qelbree with your healthcare provider.
Dosage and Administration
Qelbree is available in extended-release capsules and should be taken once daily, with or without food. The dosage of Qelbree will vary depending on the individual’s age, weight, and response to treatment. Your healthcare provider will determine the appropriate dose for you or your child and may adjust the dosage as necessary.
1. Missed Dose
If you or your child miss a dose of Qelbree, take the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and continue with the regular dosing schedule. Do not take a double dose to make up for the missed dose.
2. Overdose
In the event of a Qelbree overdose, seek immediate medical attention or contact your local poison control center. Overdose symptoms may include nausea, vomiting, dizziness, and agitation.
Side Effects
As with any medication, Qelbree may cause side effects. The most common side effects of Qelbree in patients aged 6 to 17 years include sleepiness, decreased appetite, fatigue, nausea, vomiting, trouble sleeping, and irritability. In adults, the most common side effects are insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation.
These side effects are generally mild and may improve over time as your body adapts to the medication. However, if side effects persist or worsen, inform your healthcare provider.
1. Serious Side Effects
In rare cases, Qelbree may cause more severe side effects. If you or your child experience any of the following symptoms, seek immediate medical attention:
- Suicidal thoughts or actions
- Signs of an allergic reaction, such as rash, hives, swelling of the face, lips, or tongue, or difficulty breathing
- Signs of mania, such as increased energy, racing thoughts, or impulsive behavior
- Severe headache, blurred vision, or changes in vision
- Chest pain, palpitations, or shortness of breath
Drug Interactions
Qelbree may interact with other medications, which can affect the way the drug works or increase the risk of side effects. Inform your healthcare provider of all prescription and over-the-counter medications, vitamins, and herbal supplements you or your child are taking before starting Qelbree.
1. Monoamine Oxidase Inhibitors (MAOIs)
Qelbree is contraindicated in patients taking MAOIs or who have stopped taking an MAOI within the past 14 days. Combining Qelbree with an MAOI can lead to a dangerous increase in blood pressure, a condition known as hypertensive crisis.
2. Other Medications
Certain medications should be avoided while taking Qelbree, including alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline. These medications can increase the risk of side effects or reduce the effectiveness of Qelbree. Your healthcare provider may adjust the dosage of these medications or recommend alternative treatment options.
Frequently Asked Questions
1. How long does it take for Qelbree to start working?
The exact time it takes for Qelbree to start working may vary among individuals. Some patients may notice improvements in ADHD symptoms within one to two weeks, while others may require several weeks of treatment before experiencing significant benefits.
2. Can I drink alcohol while taking Qelbree?
It is generally recommended to avoid alcohol consumption while taking Qelbree, as it may worsen the side effects of the medication, such as drowsiness and dizziness.
3. Can Qelbree be taken with other ADHD medications?
In some cases, Qelbree may be prescribed alongside other ADHD medications. However, this decision should be made by your healthcare provider based on your or your child’s specific needs and medical history.
Patient Assistance Programs
If you or your child require financial assistance to access Qelbree, several patient assistance programs may be available to help cover the cost of the medication. Contact your healthcare provider or pharmacist for more information about these programs and eligibility requirements.
Reporting Negative Side Effects
If you or your child experience negative side effects while taking Qelbree, you are encouraged to report them to the U.S. Food and Drug Administration (FDA). Visit www.fda.gov/medwatch or call 1-800-FDA-1088 to report any adverse events or side effects.
Free Fidget Spinner when you sign up
When you sign up for a free ADHD insider account you will receive a free fidget spinner along with information about ADHD medication Qelbree!
Qelbree is a prescription medication used in the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric patients aged 6 to 17 years old. It contains the active ingredient viloxazine hydrochloride, which is a selective norepinephrine reuptake inhibitor (NRI). Qelbree is specifically approved for the management of ADHD symptoms and does not contain any stimulant substances commonly found in other ADHD medications.
Qelbree works by modulating the levels of norepinephrine, a neurotransmitter involved in regulating attention and behavior. It is thought to help restore the balance of neurotransmitters in the brain, thereby reducing hyperactivity, impulsivity, and inattention associated with ADHD.
As with any medication, Qelbree may have potential side effects and should only be used under the guidance and supervision of a healthcare professional. It is important to follow the prescribed dosage and discuss any concerns or questions with a healthcare provider.
Conclusion
Qelbree is a promising new treatment option for ADHD in adults and children aged six years and older. However, it is essential to be aware of the potential risks and safety concerns associated with its use. Always consult your healthcare provider before starting any new medication, and closely monitor symptoms and side effects throughout the treatment process. With proper management and guidance from your healthcare provider, Qelbree may prove to be an effective solution for managing ADHD symptoms in you or your child.
